Drug Profile
Male contraceptive - Schering AG/Organon
Alternative Names: Etonogestrel/testosterone undecanoate; Male Pill - Schering/Organon; ORG 3236 plus testosterone undecanoate; Testosterone undecanoate/etonogestrelLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma; Organon
- Class
- Mechanism of Action Progesterone receptor agonists; Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 13 Nov 2006 Discontinued - Phase-II for Pregnancy (Prevention)/Male contraception in Europe (Intradermal)
- 23 Jan 2004 Schering and Organon has initiated enrolment in a phase II trial for Pregnancy (Prevention)/Male Contraception in 14 centres throughout Europe
- 21 Nov 2002 Phase-II clinical trials in Pregnancy (Prevention)/Male contraception in Europe (Intradermal)